Curadev Announces First Treatment Cycle Completion for the First Patient Dosed in a Phase 1a/b Clinical Trial of Allosteric STING Agonist CRD3874-SI
Feb 29, 2024
Boston [US]/Noida (Uttar Pradesh) [India], February 29: Curadev, a drug discovery and development company, announced today a significant milestone in its development of drugs...